Delivering a psychosocial program for older people living in retirement homes during the Covid-19 pandemic: A process evaluation and recommendations for community interventions

The Covid-19 pandemic lockdown regulations caused retirement homes to temporarily ban in-person visitation potentially increasing the mental health risks of older people. An opportunity arose for a multistakeholder community collaboration to design a mental health program for older people. To evaluate the process of delivering a 12-week psychosocial program aimed at preventing loneliness, countering boredom, and providing older people in restricted settings with education about Covid-19 during the lockdown, in Durban, South Africa. A qualitative retrospective design was used. Data from two focus groups and six semistructured individual interviews conducted with stakeholders (volunteers, social workers, and residents) postproject were analyzed using reflexive thematic analysis. Stakeholders had varied experiences of the project, in terms of content, processes of engagement, and implementation, resulting in five themes. The study concluded with recommendations. A strong need exists for multistakeholder community collaborations when implementing a program where the context restricts physical access.     

Factors associated with insomnia symptoms: A cross-sectional study during a Covid-19 fully restrictive lockdown

Insomnia is the most frequent sleep disorder and a public health concern that increased during the Covid 19 pandemic. Fully restrictive lockdowns during Covid are interesting periods to examine the impact of environmental and behavioural changes on the emergence of insomnia symptoms. In this cross-sectional study we aimed to (1) determine the main factors associated with insomnia symptoms during a Covid-19 fully restrictive lockdown examining the associated daily life alterations and (2) create a predictive model of insomnia symptoms. We used the data drawn from the “Covid-RythmE” study that reached volunteers from the general French population through an online survey during the last 2 weeks of the 2 month full lockdown. Associations with insomnia symptoms were tested and significant associations were entered in a Backward Stepwise Logistic Regression (BSLR) to assess the best combination to classify individuals with or without insomnia symptoms. From the 1624 participants, 50.64% suffered from mild to severe insomnia symptoms as assessed by the ISI. The best combination for explaining insomnia symptoms with 74.26% of accuracy included: age (OR = 1.15), females (OR = 1.26), smaller home sizes (OR = 0.77), environmental noises (OR = 1.59), anxiety symptoms (OR = 1.24), depressive symptoms (OR = 1.15), regularity of sleep–wake schedules (OR = 1.25), exposure to screen during the morning (OR = 1.13), and LED light during the evening (OR = 1.17). Thus, lifestyle schedule and exposure to natural synchronizers such as light, are primordial in considering in insomnia physiopathology, prevention and treatment, as well as the associated mental health status.     

Microelectrode measurements of the effects of basolateral adenosine in polarized human intestinal epithelial cells in culture

 Activation of the basolateral receptor for adenosine in HT-29cl.19A cells, by 100 μM adenosine, increased the equivalent short-circuit current (ΔI _sc= 24±2 μA/cm²), depolarized the intracellular potential (ΔV _a= 26±2 mV) and decreased the fractional apical membrane resistance (ΔfR _a=–0.48). The changes in all parameters reached their peak values simultaneously. This suggests that the primary action of the adenosine-activated pathway is on only one membrane. Bumetanide inhibited the transepithelial response and repolarized the cell potential. After preincubation with 100 μM forskolin, application of 300 μM adenosine caused a significant further change in V _a, I _sc, the transepithelial potential (V _t) and fR _a. Together with the results from ion-replacement studies, the observations indicate that adenosine activates channels other than the cystic fibrosis transmembrane conductance regulator (CFTR). The rank order of potencies of adenosine and adenosine analogues implies that the receptor is of the A₂ subtype. Preincubation with 4-bromophenacyl bromide (4-BPB) inhibited the effect of an adenosine analogue by 50%, indicating that activation of phospholipase A₂ may be involved in the adenosine-induced response. Received: 5 August 1998 / Received after revision: 12 October 1998 / Accepted: 5 November 1998     

妊娠晚期人类小DNA病毒B19感染情况,母婴传播及与早产或小于胎龄儿关系的研究

为了解妊娠晚期人类小ＤＮＡ病毒Ｂ１９（ＨＰＶＢ１９）感染情况、母婴传播及与早产或小于胎龄儿的关系，将１０４例母亲及其新生儿分成两组，试验组包括１９例早产儿、３２例小于胎龄儿及其母亲；对照组包括５３例正常新生儿及其母亲。采用聚合酶链反应技术（ＰＣＲ）检测母血、脐血和胎盘组织ＨＰＶＢ１９ＤＮＡ；用鼠抗Ｂ１９单克隆抗体和Ｂ１９联合抗原（ＶＰ１＋ＶＰ２）建立了捕获式ＥＬＩＳＡ法检测母血和脐血ＨＰＶＢ１９特异性ＩｇＭ抗体。结果：１０４例母血中，ＨＰＶＢ１９ＩｇＭ阳性２例（１．９％），１０４例脐血中阳性３例（２．９％）。在母血、脐血及胎盘组织各１０４例中检出ＨＰＶＢ１９ＤＮＡ阳性分别为６例、４例、６例。因此试验组５１对母婴共１０２例中６例有ＨＰＶＢ１９感染（５．９％）；对照组５３对母婴共１０６例中２例有ＨＰＶＢ１９感染（１．９％）。两组Ｂ１９感染率差异无显著意义。提示：在北京地区，妊娠晚期存在Ｂ１９急性感染，应引起重视；Ｂ１９感染与早产或小于胎龄儿的发生可能不相关；新生儿Ｂ１９感染是通过胎盘传播的。对有Ｂ１９感染证据的新生儿进行随访及研究如何阻止胎盘传播很重要。     

Large Scale Manufacturing of B43(Anti-CD19)-Genistein for Clinical Trials in Leukemia and Lymphoma

We have conjugated the murine monoclonal anti-CD 19 antibody B43 to the tyrosine kinase inhibitor genistein to construct an effective immunoconjugate against CD 19 antigen positive hematologic malignancies. The scaled-up production and purification of B43 antibody, genistein, and B43-Genistein immunoconjugate permitted the manufacturing of a highly purified clinical-grade B43-Genistein preparation. In clonogenic assays, B43-Genistein elicited selective and potent cytotoxicity against CD 19 antigen positive human leukemia cells. To our knowledge, this work represents the first effort of producing a clinical-grade genistein immunoconjugate for treatment of B-lineage leukemia and lymphoma.     

川山橙化学成分的研究

从川山橙Melodinushemsleyanus中分得10个化合物，用光谱方法和化学反应鉴定了它们的结构，分别为：11-hydroxytabersonine（Ⅰ），scandine（Ⅱ），10-hydroxyscandine（Ⅲ），tubotaiwine（Ⅳ），tubotaiwineN－oxide（Ⅴ），15α－hydroxykopsinine（Ⅵ），vincoline（Ⅶ），19R－vindolinineN－oxide（Ⅷ），16β-hyaroxy－19R－vindolinine（Ⅸ）和16β-hydroxy－19S－vindolinineN－oxide（Ⅹ），其中Ⅹ为新化合物，药理筛选表明化合物Ⅰ有一定的抗肿瘤活性。     

OBSERVATION ON THERAPEUTIC EFFECTS OF ACUPUNCTURE IN 64 CASES OF AUDITORY HALLUCIATION

Auditoryhallucinationisoneofcommonsymptomsofpsychosis,anditisalsoamaincauseforwhichpsychoticsharmthesociety,familyandthemselves.Fordozensofyears,theauthorshaveadoptedacupunctureatTinggongpoint(SI19)fortreatmentofauditoryhaIlucina-tion,withconsiderablesati…     

胃癌患者外周血中CK19,CK20表达的临床研究

目的:研究胃癌患者外周血CK19、CK20的表达,并探讨其临床意义.方法:用流式细胞术(FCM)方法,检测66例胃癌、7例消化系统良性疾病及21例本院健康职工外周血CK19、CK20的表达.结果:7例消化系统良性患者、21例本院健康职工外周血CK19、CK20无表达.66例胃癌患者CK19、CK20、CK19 CK20阳性表达率分别为53.1%(35/66)、56.1%(37/66)、46.9%(31/66).TNM分期之间比较,Ⅳ期与Ⅰ、Ⅱ、Ⅲ期差异有显著性意义(P＜0.01).Ⅰ、Ⅱ、Ⅲ期之间相互比较,差异无显著性意义(P＞0.05).转移程度比较,差异有显著性意义(P＜0.01).胃癌远处转移诊断敏感度高达90%.结论:胃癌患者外周血CK19、CK20可以作为检测胃癌微转移的指标.     

Regions in the brainstem and frontal cortex where electrical stimulation elicits parotid and submandibular saliva secretion in sheep

Tau proteins are encoded by a single gene which is regulated by a unique promoter. The proximal 196 base pairs of the tau 5′ flanking region confers tau protein with neuronal specific expression and nerve growth factor inducibility. We tested tau promoter activity in neuronally differentiated embryonal carcinoma cells, the P19 mouse blastoderm cell line. In these experiments, we examined the temporal expression pattern of the tau promoter and compared it to other viral and cellular promoters. Tau promoter activity increases significantly with differentiation, specifically during neurite initiation. In addition, tau promoter activity in neuronally differentiated P19 cells was significantly greater than all five of the other neuronal or non neuronal promoters tested. All other promoters displayed low levels of promoter activity throughout retinoic acid induced neuronal differentiation of P19 cells. Taken together, our results suggest that the tau promoter is a good choice for ectopic expression of exogenous genes in P19 cells, which serves as a differentiating neuronal model system.